Clinical Trials Logo

Filter by:
NCT ID: NCT00672477 Completed - Clinical trials for Opioid-Induced Constipation

Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness

Start date: June 2008
Phase: Phase 4
Study type: Interventional

This study will evaluate the safety and efficacy of methylnaltrexone administered as subcutaneous injections in subjects who have opioid-induced constipation and an advanced illness. The hypothesis is that methylnaltrexone will be safe and effective in relieving opioid-induced constipation in these subjects.

NCT ID: NCT00672347 Completed - Postoperative Pain Clinical Trials

Clonidine and Morphine in Caudal Anesthesia

Start date: July 2008
Phase: Phase 1/Phase 2
Study type: Interventional

Hypothesis: The combined use of Clonidine and Morphine in caudal anesthesia provides better postoperative analgesia than either drug alone after urogenital pediatric surgery.

NCT ID: NCT00670228 Terminated - AMI Clinical Trials

Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction

INTENSIVE
Start date: April 2008
Phase: Phase 3
Study type: Interventional

Primary objective: To demonstrate that in hyperglycemic subjects with anterior STEMI (ST Elevation Myocardial Infarction) undergoing Percutaneous Coronary Intervention (PCI), tight glycemic control using insulin glulisine and insulin glargine, i.e. Intensive Insulin Therapy (IIT), results in reducing infarct size at day 60 versus (vs) Standard Glycemic Care (SGC). Secondary objectives: To demonstrate that tight glycemic control using insulin glulisine and insulin glargine reduces markers of inflammation and improves Left Ventricular (LV) function and Cardio-Vascular (CV) outcomes from baseline values, in hyperglycemic subjects with STEMI undergoing Percutaneous Coronary Intervention (PCI).

NCT ID: NCT00670215 Completed - Clinical trials for Bacterial Infections

BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis

Start date: April 2004
Phase: Phase 3
Study type: Interventional

The primary purpose of this clinical trial is to compare in a double-blind randomized trial, the efficacy and safety of ciprofloxacin MR 1000 mg tablets given as a single-dose or as a multiple-dose regimen for the prevention of infectious complications in patients undergoing transrectal needle biopsies of the prostate (TRNBP).

NCT ID: NCT00669838 Completed - Anxiety Clinical Trials

Anesthesia for Dental Treatment in Cardiac Patients: Lidocaine Comparative Study

Start date: January 2003
Phase: N/A
Study type: Observational

Prospective, randomized double-blinded study to investigate hemodynamic changes in valvular cardiac patients during dental treatment with the use of a local anesthesia containing epinephrine.

NCT ID: NCT00669643 Completed - Leprosy Clinical Trials

Uniform Multidrug Therapy Regimen for Leprosy Patients

U-MDT
Start date: February 2007
Phase: Phase 4
Study type: Interventional

The purpose of this randomized trial is to verify if leprosy patients, despite of their classification, can be treated with the same regimen without compromising patient cure and acceptability of the treatment. At present, patients classified as multibacillary leprosy are treated for 12 months with three drugs, and patients classified as paucibacillary leprosy are treated for 6 months with two drugs. The study is going to test a unified regimen for paucibacillary and multibacillary patients by treating leprosy patients with three drugs for 6 doses.

NCT ID: NCT00669513 Completed - Sleep Deprivation Clinical Trials

Cardiovascular Effects of Partial Sleep Deprivation

Start date: January 2006
Phase: Phase 3
Study type: Interventional

Background: Sleep curtailment is common and is associated with increased mortality due to cardiovascular causes. However, the mechanisms are not completely understood.We hypothesized that partial sleep deprivation caused however significant changes in sympathetic activity and endothelial function in healthy volunteers. Methods: Thirteen young healthy male volunteers will be monitored during 12 days by sleep diary and wrist actigraphy. The subjects will keep under their usual daily activities and randomized to 5 nights of prolonged sleep (control) or partial sleep deprivation, interposed by 2 nights of unrestricted sleep (wash out). At the end of each period, the subjects will be evaluate by: 1. electrocardiogram and beat-to-beat blood pressure with spectral analysis of heart rate and blood pressure in the supine position and after head up tilt test maneuver; 2. resting plasma norepinephrine; 3. venous endothelial function (dorsal hand vein technique).

NCT ID: NCT00669058 Completed - Healthy Clinical Trials

Dermatological Evaluation of Topic Compatibility-Dermacyd Tina Gel Tangerina Mix

Start date: December 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd Tina Gel Tangerina Mix

NCT ID: NCT00668980 Completed - Down Syndrome Clinical Trials

Symbolic Representation in Young Children With Down Syndrome

Start date: July 2006
Phase: N/A
Study type: Observational

The aim of this study is to characterize the process of constitution of symbolic representation in infants with Down syndrome, as well as to investigate the relationship between gestures and the emergence of oral language. The investigators hypothesis is that children with Down syndrome could present difficulties during the constitution of symbolic representation that may be related to later deficits on expressive language, generally observed in these children.

NCT ID: NCT00668889 Completed - Healthy Clinical Trials

Dermacyd Tina Gel Tangerina Mix - Photo Evaluation

Start date: November 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to prove the absence of photo irritation and photo sensitivity potential of the product Dermacyd Tina Gel Tangerina Mix.